AFG3L2的ATPase结构域突变改变OPA1加工并导致视神经病变
该研究对286例OPA1突变阴性的视神经萎缩先证者进行靶向二代测序或全外显子测序,发现12例(4%)携带AFG3L2新变异,其中半数呈显性遗传家系,其余为散发(含新发突变),3例重型综合征性视神经病变先证者携带双等位基因变异。所有与显性视神经萎缩相关的AFG3L2突变均聚集于ATPase结构域,而SCA28相关突变多影响蛋白水解结构域;酵母和患者成纤维细胞实验证实这些突变通过异常OPA1加工导致线粒体网络碎片化,机制不同于SCA28相关突变。
要点
- AFG3L2突变是OPA1阴性视神经萎缩的致病原因之一,占本队列4%。
- DOA相关AFG3L2突变聚集于ATPase结构域,与SCA28突变分布不同。
- 突变导致OPA1异常加工和线粒体碎片化,支持OPA1通路在DOA中的作用。
核心结论
- AFG3L2突变是视神经病变的相关病因,拓展了AFG3L2突变谱及遗传机制。
研究设计与样本
- 对286例OPA1突变阴性的视神经萎缩先证者行靶向二代测序或全外显子测序。
- 在酵母和患者来源成纤维细胞中研究变异致病性及分子机制。
主要发现
- 12例(4%)先证者携带AFG3L2新变异,半数为显性遗传家系,其余散发含新发突变。
- 3例重型综合征性视神经病变先证者携带双等位基因变异,呈隐性或表型修饰作用。
- DOA相关AFG3L2突变均聚集于ATPase结构域,SCA28相关突变多影响蛋白水解结构域。
- 酵母实验证实DOA相关AFG3L2突变致病机制不同于SCA28相关突变。
- 患者成纤维细胞显示OPA1加工异常,短型异构体积累致线粒体网络碎片化,SCA28患者细胞无此现象。
关键数值与推荐
- DOA患病率为1:12,000至1:25,000,70%的DOA患者可发现OPA1突变。
临床怎么用
- 对OPA1突变阴性的视神经萎缩患者,尤其显性遗传家系,应考虑AFG3L2基因检测。
- AFG3L2相关视神经病变可表现为单纯视神经萎缩或伴综合征的重型表型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Dominant optic atrophy (DOA) is the most common inherited optic neuropathy, with a prevalence of 1:12,000 to 1:25,000. OPA1 mutations are found in 70% of DOA patients, with a significant number remaining undiagnosed. METHODS: We screened 286 index cases presenting optic atrophy, negative for OPA1 mutations, by targeted next generation sequencing or whole exome sequencing. Pathogenicity and molecular mechanisms of the identified variants were studied in yeast and patient-derived fibroblasts. RESULTS: Twelve cases (4%) were found to carry novel variants in AFG3L2, a gene that has been associated with autosomal dominant spinocerebellar ataxia 28 (SCA28). Half of cases were familial with a dominant inheritance, whereas the others were sporadic, including de novo mutations. Biallelic mutations were found in 3 probands with severe syndromic optic neuropathy, acting as recessive or phenotype-modifier variants. All the DOA-associated AFG3L2 mutations were clustered in the ATPase domain, whereas SCA28-associated mutations mostly affect the proteolytic domain. The pathogenic role of DOA-associated AFG3L2 mutations was confirmed in yeast, unraveling a mechanism distinct from that of SCA28-associated AFG3L2 mutations. Patients' fibroblasts showed abnormal OPA1 processing, with accumulation of the fission-inducing short forms leading to mitochondrial network fragmentation, not observed in SCA28 patients' cells. INTERPRETATION: This study demonstrates that mutations in AFG3L2 are a relevant cause of optic neuropathy, broadening the spectrum of clinical manifestations and genetic mechanisms associated with AFG3L2 mutations, and underscores the pivotal role of OPA1 and its processing in the pathogenesis of DOA. ANN NEUROL 2020 ANN NEUROL 2020;88:18-32.
引用
- Caporali L, Magri S, Legati A, et al. ATPase Domain AFG3L2 Mutations Alter OPA1 Processing and Cause Optic Neuropathy. Ann Neurol. 2020. PMID: 32219868. doi:10.1002/ana.25723
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。